Iqvia Holdings (IQV) Cash from Operations Growth (3y) (2015 - 2026)
Iqvia Holdings (IQV) Cash from Operations Growth (3y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 214.22 Bn | 210.16 Bn | 8.34 Bn | 11.33% |
| 2 | Danaher | 140.38 Bn | 136.03 Bn | 3.61 Bn | -9.46% |
| 3 | Idexx Laboratories | 46.15 Bn | 45.95 Bn | 779.09 Mn | 20.12% |
| 4 | Agilent Technologies | 39.80 Bn | 37.99 Bn | 990.00 Mn | -11.38% |
| 5 | Iqvia Holdings | 39.51 Bn | 37.43 Bn | 1.44 Bn | 11.55% |
| 6 | Natera | 38.83 Bn | 37.73 Bn | 696.04 Mn | 35.64% |
| 7 | Illumina | 30.02 Bn | 28.85 Bn | 770.00 Mn | 24.17% |
| 8 | Mettler Toledo International | 28.64 Bn | 28.59 Bn | 650.22 Mn | 5.18% |
| 9 | Quest Diagnostics | 26.17 Bn | 25.54 Bn | 1.03 Bn | 10.37% |
| 10 | Labcorp Holdings | 25.90 Bn | 24.92 Bn | 1.01 Bn | 16.47% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 11.55% |
| Mar 31, 2026 | 14.01% |
| Dec 31, 2025 | 9.49% |
| Sep 30, 2025 | 1.71% |
| Jun 30, 2025 | 10.43% |
| Mar 31, 2025 | 3.79% |
| Dec 31, 2024 | 8.55% |
| Sep 30, 2024 | -5.11% |
| Jun 30, 2024 | 2.94% |
| Mar 31, 2024 | -15.56% |
| Dec 31, 2023 | -0.13% |
| Sep 30, 2023 | 0.52% |
| Jun 30, 2023 | -5.21% |
| Mar 31, 2023 | 36.77% |
| Dec 31, 2022 | -1.33% |
| Sep 30, 2022 | 37.77% |
| Jun 30, 2022 | -5.59% |
| Mar 31, 2022 | 65.04% |
| Dec 31, 2021 | 18.39% |
| Sep 30, 2021 | 34.87% |